MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

Search

Teva Pharmaceutical Industries Ltd.

Închisă

SectorSănătate

13.81 -6.75

Rezumat

Modificarea prețului

24h

Curent

Minim

13.35

Maxim

14.81

Indicatori cheie

By Trading Economics

Venit

162M

-275M

Vânzări

-103M

4.2B

EPS

0.71

Marjă de profit

-6.503

Angajați

33,892

EBITDA

51M

261M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+60.67% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

18B

Deschiderea anterioară

20.56

Închiderea anterioară

13.81

Sentimentul știrilor

By Acuity

50%

50%

167 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Teva Pharmaceutical Industries Ltd. Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 dec. 2024, 19:39 UTC

Principalele dinamici ale pieței

Correction to Teva Articles

17 dec. 2024, 16:24 UTC

Principalele dinamici ale pieței

Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment

17 dec. 2024, 16:14 UTC

Achiziții, Fuziuni, Preluări

These Stocks Are Moving the Most Today: Nvidia, Tesla, Broadcom, Pfizer, EVgo, Teva, SolarEdge, Affirm, and More -- Barrons.com

17 dec. 2024, 13:51 UTC

Achiziții, Fuziuni, Preluări

These Stocks Are Moving the Most Today: Nvidia, Tesla, Broadcom, Pfizer, EVgo, Teva, SolarEdge, Red Cat, and More -- Barrons.com

23 nov. 2024, 12:00 UTC

Top știri

Emerging-Markets Stocks Have Rarely Been So Hated. It's Time To Buy -- WSJ

22 aug. 2024, 05:30 UTC

Top știri

Generic Weight-Loss Drugs Won't Come for Years -- Barrons.com

7 mai 2024, 20:30 UTC

Top știri

Teva Earnings Are Soon. What Could Keep the Stock Gains Going. -- Barrons.com

Comparație

Modificare preț

Teva Pharmaceutical Industries Ltd. Așteptări

Obiectiv de preț

By TipRanks

60.67% sus

Prognoză pe 12 luni

Medie 23.86 USD  60.67%

Maxim 30 USD

Minim 20 USD

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruTeva Pharmaceutical Industries Ltd. - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

8 ratings

7

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

14.7 / 15.09Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

167 / 386 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.